Academic Identity

Profile Links

Vidwan-ID : 64380

Edit Profile


  • Dr Ganesh Venkatraman

  • Professor
  • Sri Ramachandra Institute of Higher Education and Research
Publications 2002 - 2024

Publications

  • 86
    Journal Articles
  • 5
    Book Chapter
  • 17
    Review
  • 2
    Editorial
  • 11
    Projects
  • 9
  • 6
  • 6
  • 61

Citations / H-Index

1889 Citations
18 h-index
1552 Citations

Altmetrics

84
50
106
1586
10

Co-author Network

Expertise

Biochemistry and Molecular Biology

Molecular Oncology, Cell Biology, Cell Signalling, Drug Screening, Nanomedicine

Personal Information

Dr Ganesh Venkatraman

Male
Human Genetics, Sri Ramachandra University Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research
Chennai, Tamil Nadu, India - 600116

Experience

  • Professor

    Department of Human Genetics

    Sri Ramachandra Institute of Higher Education and Research

Qualification

  • Ph.D

    Cancer Institute Chennai (WIA)

Honours and Awards

2019

Shri.R.Dakshinamurthy and Smt. Adhilakshmiammal Best research publication Gold Medal

SRIHER

2018

Certification of merit for publication with high impact factor

SRIHER

2017

Certification of merit for publication with high impact factor

SRIHER

Read More
2019

Shri.R.Dakshinamurthy and Smt. Adhilakshmiammal Best research publication Gold Medal

SRIHER

2018

Certification of merit for publication with high impact factor

SRIHER

2017

Certification of merit for publication with high impact factor

SRIHER

2017

National best teacher award

C.V.S Krishna Murthy Theja Charities, Tirupati

2016

Dr. Vinod Kumar Bhargava award, Best Research Publication

National Academy of Medical Sciences (India)

Read Less

Doctoral Theses Guided

2019

Bioactivity of novel glycoheterocyclic compounds

Mr B Hemadev, Sri Ramachandra Medical College and Research Institute

2018

Biological evaluation of dipeptide coated magnetic nanoparticles in lung cancer models under pulsed electromagnetic field

Ms Ganga B, Sri Ramachandra Medical College and Research Institute

2017

Bioactivity of -lactam substituted polycyclic fused pyrrolidine pyrrolizidine derivatives: in vitro, in vivo & in silico studies

Gowri , Sri Ramachandra Medical College and Research Institute

Read More
2019

Bioactivity of novel glycoheterocyclic compounds

Mr B Hemadev, Sri Ramachandra Medical College and Research Institute

2018

Biological evaluation of dipeptide coated magnetic nanoparticles in lung cancer models under pulsed electromagnetic field

Ms Ganga B, Sri Ramachandra Medical College and Research Institute

2017

Bioactivity of -lactam substituted polycyclic fused pyrrolidine pyrrolizidine derivatives: in vitro, in vivo & in silico studies

Gowri , Sri Ramachandra Medical College and Research Institute

2016

Synthesis and characterization of diglycolamic acid functionalized and anti-HER2 targeted polyamidoamine dendrimer- cisplatin nanoparticles for the treatment of cancer

Ms Akila K, Sri Ramachandra Medical College and Research Institute

2016

Molecular mechanism of anticancer activity of phycocyanin in triple negative breast cancer cells

Ms Mathangi R, Sri Ramachandra Medical College and Research Institute

2015

Antimicrobial activity of cationic synthetic peptides

Ms Sofi Beula W, SRIHER

Read Less

Membership In Professional Bodies

2016

American Chemical Society USA

Life Member

2012

Association of Clinical Biochemists of India (ACBI)

Life Member

2016

American Chemical Society USA

Life Member

2012

Association of Clinical Biochemists of India (ACBI)

Life Member

Read Less

Membership In Committees

2019

Institutional Ethics Committee, SRMC & RI

Member Secretary -

2015

IIT M Technical Committee

Member

2014

DAE External Expert for monitoring CARRT & MAC Facility

Member

2019

Institutional Ethics Committee, SRMC & RI

Member Secretary -

2015

IIT M Technical Committee

Member

2014

DAE External Expert for monitoring CARRT & MAC Facility

Member

Read Less

Research Projects

Modulating post translational modification of the oncogenic signaling kinase p21-activated kinase-1

Funding Agency : DAE_BRNS

Design & Screening of novel small molecules as potential inhibitors of the oncogenic signalling kinase PAK1 for Glioblastoma multiforme

Funding Agency : SERB

Investigating serum PAK1 as a diagnostic and prognostic marker in breast cancer patients

Funding Agency : DAE_BRNS

Read More

Modulating post translational modification of the oncogenic signaling kinase p21-activated kinase-1

Funding Agency : DAE_BRNS

Design & Screening of novel small molecules as potential inhibitors of the oncogenic signalling kinase PAK1 for Glioblastoma multiforme

Funding Agency : SERB

Investigating serum PAK1 as a diagnostic and prognostic marker in breast cancer patients

Funding Agency : DAE_BRNS

PAK-1 as a therapeutic target in Glioma

Funding Agency : DBT

Synthesis and antiproliferative activity of novel glycoprrolidines

Funding Agency : SERB

Synthesis and evaluation of Novel Curcumin conjugates and hybrids as potential anti-cancer agents

Funding Agency : SERB

Production of immunoassay compatible monoclonal antibodies against human thyroid stimulating hormone (hTSH) and their application in Immunoassay development

Funding Agency : DAE_BRNS

Investigating the role of P21 activated kinase 1 (Pak1) signaling in pancreatic adenocarcinoma (PDAC)

Funding Agency : DBT

99mTc radiolabeled dendrimer drug conjugates targeted to ovarian cancer cells

Funding Agency : DAE_BRNS

Phycocyanin - a novel COX-2 inhibitor for chemotherapy of epithelial neoplasms

Funding Agency : SERB

Assessment for Pre-clinical utility of peptide nanostructures

Funding Agency : DBT-RGYI

Read Less

Publications (110)

Powered by